In our latest blog, Neil McSporran, global portfolio manager at the NSG Group, outlines how Pilkington SaniTise™ will help architects meet the rising priority of infection control.
COVID-19 has proven just how fast infectious diseases can spread in the modern world.
To control the virus, governments have overthrown social norms with the introduction of measures like social distancing and mask wearing, while piling investment into vaccine research and rollout.
The next step to create a safer and healthier world will be to pandemic proof many touchpoints in our everyday lives – and innovative new glass has an important role to play.
Infection prevention and control measures have crept up the list of priorities for architects’ and building managers’ clients. And delivering projects that adhere to such criteria is no longer just the domain of healthcare building design specialists.
Architects, developers and those in the supply chain can each be influential in driving effective change. Creating a safer environment can stem from simple retrofits specifying innovative building materials, to the proliferation of post-Covid urban design and development.
We launched a new solution, Pilkington SaniTise™
, to help technical architects and developers upgrade and create spaces with enhanced protection against infections, as they look for innovation in the supply chain.
is a transparent coated glass that is deposited directly onto the glass surface during its manufacturing process and activated through UV radiation.
obtained third party verification after being tested to ISO 21702:2019, a measurement of antiviral activity on plastics and other non-porous surfaces.
Working in two stages, it reacts with water vapour within the air in a photocatalytic process that produces reactive oxygen species. These reactive oxygen species enable the breakdown of organic species, helping provide antimicrobial properties and activity against enveloped viruses on the glass surface.
A number of leading UK universities have also tested the coating against viruses and bacteria, and the product even won Design of the Year at British Glass’ Glass Focus 2020 awards in November.
Our antimicrobial glass can help to reduce the chance of infection contact transmission in higher risk settings like hospitals, schools, GP surgeries, restaurants, transport hubs and more.
Meanwhile, the launch of Pilkington SaniTise™
represents the increasingly expansive role that modern glass plays in the built environment – from enhancing measures for infection prevention and control, to capturing air pollution by the roadside
And we’re proud to be leading this innovation from our base in the UK.
Find out more about Pilkington SaniTise™